Metrikler
Yayın
81
Açık Erişim
8
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (59)
SCI-E, SSCI, AHCI (57)
SCI-E, SSCI, AHCI, ESCI (59)
ESCI (2)
Scopus (57)
TRDizin (6)
2017
20171. Prognostic role of inflammatory biomarkers in metastatic breast cancer
Petekkaya I., Unlu O., Roach E. C., Gecmez G., Okoh A. K., BABACAN T., et al.
JOURNAL OF BUON
, cilt.22, sa.3, ss.614-622, 2017 (SCI-Expanded, Scopus)
2017
20172. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients
Karatas F., Erdem G. U., Sahin S., Aytekin A., YÜCE D., SEVER A. R., et al.
BREAST
, cilt.32, ss.237-244, 2017 (SCI-Expanded, Scopus)
2017
20173. A case of vemurafenib-induced polyarhritis in a patient with melanoma: how to manage it?
BABACAN T., Turkbeyler I. H., Balakan O., Pehlivan Y., Suner A., Kisacik B.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.20, sa.3, ss.398-401, 2017 (SCI-Expanded, Scopus)
2017
20174. Risk factors and histopathological features of breast cancer among women with different menopausal status and age at diagnosis
Unlu O., Kiyak D., Caka C., Yagmur M., Yavas H. G., Erdogan F., et al.
JOURNAL OF BUON
, cilt.22, sa.1, ss.184-191, 2017 (SCI-Expanded, Scopus)
2016
20165. Patients' understanding of treatment goals and disease course and their relationship with optimism, hope, and quality of life: a preliminary study among advanced breast cancer outpatients before receiving palliative treatment
SOYLU C., BABACAN T., SEVER A. R., Altundag K.
SUPPORTIVE CARE IN CANCER
, cilt.24, sa.8, ss.3481-3488, 2016 (SCI-Expanded, Scopus)
2016
20166. Left laterality is an independent prognostic factor for metastasis in N3 stage breast cancer
Karatas F., Sahin S., Erdem G. U., ATEŞ Ö., BABACAN T., AKIN S., et al.
JOURNAL OF BUON
, cilt.21, sa.4, ss.851-858, 2016 (SCI-Expanded, Scopus)
2016
20167. Trastuzumab 1-year vs 9-week in early-stage HER2-positive, lymph node negative breast cancer patients
Ozen M., Gunduz M., ATEŞ Ö., BABACAN T., SEVER A. R., AKIN S., et al.
JOURNAL OF BUON
, cilt.21, sa.4, ss.799-808, 2016 (SCI-Expanded, Scopus)
2016
20168. Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience
Sarici F., BABACAN T., Buyukhatipoglu H., Balakan O., SEVER A. R., KERTMEN N., et al.
JOURNAL OF BUON
, cilt.21, sa.4, ss.826-831, 2016 (SCI-Expanded, Scopus)
2016
20169. Depression and socio-economical burden are more common in primary caregivers of patients who are not aware of their cancer: TURQUOISE Study by the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
Tanriverdi O., Yavuzsen T., Turhal S., Kilic D., YALÇIN S. S., Ozkan A., et al.
EUROPEAN JOURNAL OF CANCER CARE
, cilt.25, sa.3, ss.502-515, 2016 (SCI-Expanded, SSCI, Scopus)
2016
201610. Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors
ATEŞ Ö., SOYLU C., BABACAN T., Sarici F., KERTMEN N., Allen D., et al.
SPRINGERPLUS
, cilt.5, 2016 (SCI-Expanded, Scopus)
2016
201611. Leg cramps associated with tamoxifen use - possible mechanism and treatment recommendations
Karatas F., Sahin S., BABACAN T., AKIN S., SEVER A. R., Altundag K.
JOURNAL OF BUON
, cilt.21, sa.2, ss.520, 2016 (SCI-Expanded, Scopus)
2016
201612. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer
ATEŞ Ö., BABACAN T., KERTMEN N., Sarici F., Cenoli A., AKIN S., et al.
JOURNAL OF BUON
, cilt.21, sa.2, ss.375-381, 2016 (SCI-Expanded, Scopus)
2016
201613. Prognostic Factors In Breast Cancer Patients With Hepatic Metastases: Impact Of Molecular Subtype And Local Hepatic Treatment
ATEŞ Ö., GÜVEN D. C., BABACAN T., Sunar V., Sarici F., AKSOY S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.4, ss.206-214, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201614. Anthracyclin - Based Chemotherapy in Patients with Non-Hodgkin Lymphoma Aged Over 75
Sarici F., KERTMEN N., Aslan A. C., Tasdemir V., BABACAN T., KILIÇKAP S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.2, ss.89-95, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201515. Insomnia caused by aromatase inhibitors; a therapeutic challenge in patients with breast cancer
Karatas F., Sahin S., BABACAN T., AKIN S., SEVER A. R., Altundag K.
JOURNAL OF BUON
, cilt.20, sa.6, ss.1640, 2015 (SCI-Expanded, Scopus)
2015
201516. Does eribulin mesylate cause recurrent transient diplopia?
Karatas F., Hacioglu B., AKIN S., BABACAN T., SEVER A. R., Altundag K.
JOURNAL OF BUON
, cilt.20, sa.5, ss.1379, 2015 (SCI-Expanded, Scopus)
2015
201517. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer
BABACAN T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., Balakan O., et al.
TUMORI J
, cilt.101, sa.4, ss.418-423, 2015 (SCI-Expanded, Scopus)
2015
201518. The effect of obesity on recurrence pattern in early breast cancer patients
Yazici O., AKSOY S., Sendur M. A. N., BABACAN T., Ozdemir N., Ozisik Y., et al.
JOURNAL OF BUON
, cilt.20, sa.4, ss.954-962, 2015 (SCI-Expanded, Scopus)
2015
201519. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality
Solak M., Turkoz F. P., Keskin O., AKSOY S., BABACAN T., Sarici F., et al.
JOURNAL OF BUON
, cilt.20, sa.3, ss.737-745, 2015 (SCI-Expanded, Scopus)
2015
201520. Can aromatase inhibitors cause forgetfulness in women with breast cancer ?
Karatas F., AKIN S., BABACAN T., SEVER A. R., Altundag K.
JOURNAL OF BUON
, cilt.20, sa.3, ss.935, 2015 (SCI-Expanded, Scopus)
2015
201521. Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis
BABACAN T., Buyukhatipoglu H., Balakan O., KERTMEN N., Suner A., Sarici F., et al.
JOURNAL OF BUON
, cilt.20, sa.2, ss.479-486, 2015 (SCI-Expanded, Scopus)
2015
201522. Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab
ATEŞ Ö., Sunar V., BABACAN T., AKIN S., KERTMEN N., Altundag K.
JOURNAL OF BUON
, cilt.20, sa.1, ss.349, 2015 (SCI-Expanded, Scopus)
2015
201523. A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer
Buyukhatipoglu H., BABACAN T., KERTMEN N., Balakan O., Suner A., ATEŞ Ö., et al.
JOURNAL OF BUON
, cilt.20, sa.1, ss.22-27, 2015 (SCI-Expanded, Scopus)
2015
201524. Molecular subtypes in patients with inflammatory breast cancer; A single center experience
KERTMEN N., BABACAN T., Keskin O., Solak M., Sarici F., AKIN S., et al.
JOURNAL OF BUON
, cilt.20, sa.1, ss.35-39, 2015 (SCI-Expanded, Scopus)
2015
201525. Cerebellar Abscess In A Metastatic Esophageal Cancer Patient: A Rare Entity
BİLGİN E., BABACAN T., Zengin O., Gokduman K., MUTLU D.
EUROPEAN JOURNAL OF THERAPEUTICS
, cilt.21, sa.1, ss.73-74, 2015 (ESCI, TRDizin)
2015
201526. A systemic late recurrence after the first operation in a patient diagnosed with early-stage breast cancer: the latest recurrence in the literature
Keskin O. D., KERTMEN N., Karakas Y., BABACAN T., ARIK Z., Altundag K., et al.
JOURNAL OF BUON
, cilt.20, sa.1, ss.348, 2015 (SCI-Expanded, Scopus)
2015
201527. The Synchronous Primary Carcinomas of the Rectum and Thymus
BABACAN T., Dag S., Sarici F., Dilli I., Turkbeyler I. H., Altundag K.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.25, sa.2, ss.143-144, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201528. How long should we maintain anti-HER2 therapy for metastatic breast cancer patients with complete remission?
Hacioglu B., AKIN S., BABACAN T., SEVER A. R., Altundag K.
FUTURE ONCOLOGY
, cilt.11, sa.20, ss.2799-2801, 2015 (SCI-Expanded, Scopus)
2015
201529. Comparison of three different induction regimens for nasopharyngeal cancer
KERTMEN N., AKSOY S., CENGİZ M., YAZICI G., KESKİN O., Babacan T., et al.
Asian Pacific Journal of Cancer Prevention
, cilt.16, sa.1, ss.59-63, 2015 (SCI-Expanded, Scopus)
2015
201530. The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+breast cancer patients
BABACAN T., Balakan O., Kuzan T. Y., Sarici F., Koca E., KERTMEN N., et al.
JOURNAL OF BUON
, cilt.20, sa.1, ss.50-56, 2015 (SCI-Expanded, Scopus)
2014
201431. Acute erythroid leukemia in a patient with chronic lymphocytic leukemia
GÜVEN D. C., BABACAN T., Sarici F., AKIN S., Altundag K., Turker A.
JOURNAL OF BUON
, cilt.19, sa.4, ss.1127, 2014 (SCI-Expanded, Scopus)
2014
201432. The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer
Balakan O., KALENDER M. E., Suner A., Cengiz B., ÖZTUZCU S., Bayraktar R., et al.
MEDICAL SCIENCE MONITOR
, cilt.20, ss.1419-1425, 2014 (SCI-Expanded, Scopus)
2014
201433. Impact of inflammatory markers on the prognosis of patients with operable breast cancer
Petekkaya I., AKSOY S., Roach E. C., Okoh A. K., Gecmez G., Gezgen G., et al.
JOURNAL OF BUON
, cilt.19, sa.3, ss.673-680, 2014 (SCI-Expanded, Scopus)
2014
201434. Breast sarcoma: A rare malignancy
Gul G., BABACAN T., AKIN S., Sarici F., Altundag K.
JOURNAL OF BUON
, cilt.19, sa.2, ss.577, 2014 (SCI-Expanded, Scopus)
2014
201435. Tertiary Cancer Center Experience: Pregnancy-Associated Breast Cancer
Kuzas T. Y., Koca E., BABACAN T., Turkbeyler I. H., Sarici F., Altundag K.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.4, ss.284-285, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201436. A novel targeted therapy in breast cancer: Cyclin dependent kinase inhibitors
AKIN S., BABACAN T., Sarici F., Altundag K.
JOURNAL OF BUON
, cilt.19, sa.1, ss.42-46, 2014 (SCI-Expanded, Scopus)
2014
201437. Successful treatment of myeloid sarcoma with local treatment modalities: The longest overall survival in published literature
Aladag E., Babacan T., Akin S., Uner U., Kars A., Altundag K.
JOURNAL OF BUON
, cilt.19, sa.1, ss.316-317, 2014 (SCI-Expanded, Scopus)
2014
201438. Cetuximab-induced esophageal ulcer: the first report in literature
BABACAN T., Turkbeyler I. H., Dag M. S., Dilli I., Balakan O., Altundag K.
LIBYAN JOURNAL OF MEDICINE
, cilt.9, 2014 (SCI-Expanded, Scopus)
2014
201439. Metaplastic Breast Carcinoma: a Heterogeneous Disease
GÜLTEKİN M., Eren G., Babacan T., YILDIZ F., Altundag K., GÜLER N., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.6, ss.2851-2856, 2014 (SCI-Expanded, Scopus)
2013
201340. Impact of the obesity on lymph node status in operable breast cancer patients
Keskin O., Aksoy S., Babacan T., Sarici F., Kertmen N., Solak M., et al.
JOURNAL OF BUON
, cilt.18, sa.4, ss.824-830, 2013 (SCI-Expanded, Scopus)
2013
201341. Outcomes of locally advanced breast cancer patients with >= 10 positive axillary lymph nodes
KOCA E., KUZAN T. Y., Dizdar O., Babacan T., SAHIN I., ARARAT E., et al.
MEDICAL ONCOLOGY
, cilt.30, sa.3, 2013 (SCI-Expanded, Scopus)
2013
201342. Bilateral transient regional osteoporosis of the hip: case report
Sarica M. A., Turkbeyler I. H., BABACAN T., TOSUN H. B., Bulut T.
EUROPEAN JOURNAL OF THERAPEUTICS
, cilt.19, sa.3, ss.207-209, 2013 (ESCI, TRDizin)
2013
201343. Successful treatment of benign metastasizing leiomyoma with oral alternated chemotherapeutic agents
Sarici F., Babacan T., Altundag K., Balakan O., Gullu I.
JOURNAL OF BUON
, cilt.18, sa.3, ss.799, 2013 (SCI-Expanded, Scopus)
2013
201344. Medullary carcinoma of the breast: A brief report from a tertiary care center
Petekkaya I., Babacan T., Sarici F., Gezgen G., Roach E. C., Kizilarslanoglu M. C., et al.
JOURNAL OF BUON
, cilt.18, sa.3, ss.798, 2013 (SCI-Expanded, Scopus)
2013
201345. Association between common risk factors and molecular subtypes in breast cancer patients
Turkoz F. P., Solak M., Petekkaya I., Keskin O., KERTMEN N., Sarici F., et al.
BREAST
, cilt.22, sa.3, ss.344-350, 2013 (SCI-Expanded, Scopus)
2013
201346. Granulocyte colony stimulating factor-induced tumor lysis-like syndrome: leucolysis
Babacan T., Sarici F., Gokhan A., Balakan O., Keskin O., Altundag K.
JOURNAL OF BUON
, cilt.18, sa.2, ss.549-550, 2013 (SCI-Expanded, Scopus)
2013
201347. Adult Langerhans' cell histiocytosis: a rare cause of parotid gland enlargement
Babacan T., Turkbeyler I. H., Zengin O., Gokhan A., Sarici F., Altundag K.
JOURNAL OF BUON
, cilt.18, sa.2, ss.546-547, 2013 (SCI-Expanded, Scopus)
2013
201348. Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer
Boyraz B., Sendur M. A. N., AKSOY S., BABACAN T., Roach E. C., KIZILARSLANOĞLU M. C., et al.
CURRENT MEDICAL RESEARCH AND OPINION
, cilt.29, sa.4, ss.405-414, 2013 (SCI-Expanded, Scopus)
2013
201349. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women
Turkoz F. P., Solak M., Petekkaya I., Keskin O., Kertmen N., Sarici F., et al.
JOURNAL OF BUON
, cilt.18, sa.2, ss.335-341, 2013 (SCI-Expanded, Scopus)
2013
201350. Vemurafenib-induced hypertension: is it real?
Balakan O., Babacan T., Altundag K.
JOURNAL OF BUON
, cilt.18, sa.2, ss.545, 2013 (SCI-Expanded, Scopus)
2013
201351. Colon involvement in a chronic lymphocytic leukemia patient
Sarici F., Babacan T., Petekkaya I., Gezgen G., Roach E. C., Altundag K.
JOURNAL OF BUON
, cilt.18, sa.1, ss.291-292, 2013 (SCI-Expanded, Scopus)
2013
201352. Safety of Tamoxifen During Pregnancy: 3 Case Reports and Review of the Literature
Koca E., Kuzan T. Y., BABACAN T., Turkbeyler I. H., Sarici F., Altundag K.
BREAST CARE
, cilt.8, sa.6, ss.453-454, 2013 (SCI-Expanded, Scopus)
2013
201353. Frequency of thyroid disease among breast cancer patients: a descriptive study of breast cancer patients
Vural O., Dizdar O., Petekkaya I., Alnak A., Babacan T., Altundag K.
JOURNAL OF BUON
, cilt.18, sa.1, ss.294-295, 2013 (SCI-Expanded, Scopus)
2012
201254. Association between family history and clinicopathologic characteristics in 1987 breast cancer patients: single institution experience from Turkey
Turkoz F. P., Solak M., Aksoy S., Petekkaya I., Keskin O., Kertmen N., et al.
JOURNAL OF BUON
, cilt.17, sa.4, ss.649-657, 2012 (SCI-Expanded, Scopus)
2012
201255. Comparison of clinicopathological characteristics and outcome of younger and older breast cancer patients
Kertmen N., Sahin U., Keskin O., Solak M., Petekkaya I., Babacan T., et al.
JOURNAL OF BUON
, cilt.17, sa.4, ss.797, 2012 (SCI-Expanded, Scopus)
2012
201256. Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor
Kuria I. M., Petekkaya I., Hasanov E., Babacan T., Dizdar O., Altundag K.
JOURNAL OF BUON
, cilt.17, sa.4, ss.798-799, 2012 (SCI-Expanded, Scopus)
2012
201257. Vismodegib in Advanced Basal-Cell Carcinoma
BABACAN T., Sarici F., Altundag K.
NEW ENGLAND JOURNAL OF MEDICINE
, cilt.367, sa.10, ss.969-970, 2012 (SCI-Expanded, Scopus)
2012
201258. Clinical and pathological characteristics of patients 80 years and older with breast cancer
Tosur M., Sahin I., Ararat E., Babacan T., Altundag K.
JOURNAL OF BUON
, cilt.17, sa.2, ss.397-398, 2012 (SCI-Expanded, Scopus)
2012
201259. Sunitinib-Induced Autoimmune Thyroiditis in a Patient with Metastatic Renal Cell Carcinoma: A Case Report
Babacan T., Sevinc A., Akarsu E., Balakan O.
CHEMOTHERAPY
, cilt.58, sa.2, ss.142-145, 2012 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2016
20161. Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study
DEMİRCİ N., AKSOY S., ÖZDEMİR N., Babacan T., ERDEM G. U., BOZKAYA Y., et al.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri)
2015
20152. Pleomorphic lobular carcinoma of the breast associated with impaired overall survival
Hacioglu M. B., Babacan T., Diker O., Akin S., Demir M., Dizdar O., et al.
European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51, (Özet Bildiri)
2015
20153. Kadri Altundag Taner Babacan Orhan Efe Ahmet S Hasırcı Fatih Demirci Hakan Buyukhatıpoglu Ozan Balakan Furkan Saim Sarıcı Neyran Kertmen Ece Esin Serkan Akin Ozturk Ates Sercan Aksoy Ali R Sever
ALTUNDAĞ M. K., Babacan T., EFE O., HASIRCI A. S., DEMİRCİ F., BUYUKHATİPOGLU H., et al.
2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri)
2015
20154. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer
Ateş Ö., Babacan T., SARICI F., KERTMEN N., CENOLİ A., Akın S., et al.
ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri)
2015
20155. Tumor locations significantly affect disease free survival and overall survival
BUYUKHATİPOGLU H., Babacan T., KERTMEN N., Ateş Ö., AKTAŞ G., ŞENDUR M. A. N., et al.
2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri)
2015
20156. Factors that affect the suitability of cancer patients for clinical drug trials in Turkey: Final analysis of a multicenter study.
Erman M., Kilickap S., Ekinci A. S., Koca S., Ata A., Besen A., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
20157. Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience.
Diker O., Babacan T., Buyukhatipoglu H., Kertmen N., Balakan O., Sever A. R., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
20148. Efficacy of adjuvant tamoxifen in hormone receptor-positive premenopausal breast cancer patients according to the body mass index
Altundag K., Sendur M. A. N., AKSOY S., BABACAN T., Ozisik Y.
37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 9 - 13 Aralık 2014, cilt.75, (Özet Bildiri)
2015
20159. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER-2 negative breast cancer.
Altundag K., Babacan T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
201410. Predictive value of semi-quantitative parameters of 18 FDG PET/CT for bone marrow involvement in patients with non-Hodgkin lymphoma.
TUNCEL M., Kupik O., Babacan T., ÜNER A., TÜRKER A., Kars A., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, İsveç, 18 - 22 Ekim 2014, cilt.41, (Özet Bildiri)
2014
201411. Do semi-quantitative parameters, obtained from PET and CT component of PET/CT study, help for the differential diagnosis between anemia related changes vs. bone marrow involvement?
TUNCEL M., Kupik O., Babacan T., ÜNER A., TÜRKER A., Kars A., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, İsveç, 18 - 22 Ekim 2014, cilt.41, (Özet Bildiri)
2014
201412. Comparison of three different induction regimen in nasopharyngeal cancer: CF versus DC versus DCF.
Kertmen N., Aksoy S., Cengiz M., Yazici G., Keskin O., Babacan T., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
201413. Is there any correlation between molecular subtypes and blood groups in breast cancer?
Kucukoztas N., Oguz A., Babacan T., Dizdar O., Rahatli S., Sarici S. F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
201414. Which sequence prevents the heart from trastuzumab and anthracycline toxicity: Electron microscopy study in rats
Aksoy S., Kertmen N., ÜNER A., Sargon M., Ozkayar O., Keskin O., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
201415. Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes.
Oguz A., Babacan T., Dizdar O., Kucukoztas N., Rahatli S., Keskin G. S. Y., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2013
201316. Metaplastic breast carcinoma: A heterogeneous disease
GÜLTEKİN M., Eren G., Babacan T., Yazici G., Hurmuz P., Yildiz F., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri)
2013
201317. Inflammatory markers in metastatic breast cancer.
Sahin U., Petekkaya H., Gecmez G., Babacan T., Roach E. C., Sarici S. F., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201318. The number of metastatic lymph node in N3M0 breast cancer and influence on survival.
Solak M., Turkoz F. P., Keskin O., Petekkaya H., Sarici S. F., Babacan T., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201319. Association of the neutrophil to lymphocyte ratio with survival patients with in metastatic breast cancer.
Unlu O., Aygun S., Petekkaya H., Gecmez G., Roach E. C., Babacan T., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2012
201220. DO THE WELL-KNOWN RISK FACTORS OF BREAST CANCER HAVE THE SAME IMPACT ON DEVELOPMENT OF MOLECULAR SUBTYPES?
Turkoz F. P., Solak M., Keskin O., Arik Z., Sarici F. S., Petekkaya I. H., et al.
37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.543-544, (Özet Bildiri)
2012
201221. Nine-weeks of adjuvant trastuzumab in HER2-positive breast cancer: A single center experience
Kizilarslanoglu C., Petekkaya I., Babacan T., Altundag K.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
201222. Outcome of breast cancer patients with stage I diesease: A retrospective analysis
Ergun A., Kucukoztas N., Yalcin S., Rahatli S., Babacan T., Yagmurdur M. C., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)